AU7256596A - Process for isolating immunoglobulins in whey - Google Patents
Process for isolating immunoglobulins in wheyInfo
- Publication number
- AU7256596A AU7256596A AU72565/96A AU7256596A AU7256596A AU 7256596 A AU7256596 A AU 7256596A AU 72565/96 A AU72565/96 A AU 72565/96A AU 7256596 A AU7256596 A AU 7256596A AU 7256596 A AU7256596 A AU 7256596A
- Authority
- AU
- Australia
- Prior art keywords
- whey
- isolating immunoglobulins
- immunoglobulins
- isolating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108060003951 Immunoglobulin Proteins 0.000 title 1
- 239000005862 Whey Substances 0.000 title 1
- 102000007544 Whey Proteins Human genes 0.000 title 1
- 108010046377 Whey Proteins Proteins 0.000 title 1
- 102000018358 immunoglobulin Human genes 0.000 title 1
- 229940072221 immunoglobulins Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/04—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from milk
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1002—Coronaviridae
- C07K16/1003—Severe acute respiratory syndrome coronavirus 2 [SARS‐CoV‐2 or Covid-19]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/121—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Helicobacter (Campylobacter) (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K16/1232—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia from Escherichia (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1239—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Vibrionaceae (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
- C07K16/1282—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Clostridium (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US623276 | 1984-06-21 | ||
US539539 | 1995-10-05 | ||
US08/539,539 US5747031A (en) | 1995-10-05 | 1995-10-05 | Process for isolating immunoglobulins in whey |
US62327696A | 1996-03-28 | 1996-03-28 | |
PCT/US1996/015945 WO1997012901A1 (en) | 1995-10-05 | 1996-10-04 | Process for isolating immunoglobulins in whey |
Publications (1)
Publication Number | Publication Date |
---|---|
AU7256596A true AU7256596A (en) | 1997-04-28 |
Family
ID=27066118
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU72565/96A Abandoned AU7256596A (en) | 1995-10-05 | 1996-10-04 | Process for isolating immunoglobulins in whey |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0859783A1 (en) |
JP (1) | JPH11512746A (en) |
AU (1) | AU7256596A (en) |
CA (1) | CA2233935A1 (en) |
WO (1) | WO1997012901A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003055502A1 (en) * | 2001-12-24 | 2003-07-10 | Fonterra Co-Operative Group Limited | Immunoglobulin composition |
CN1787829B (en) | 2003-03-14 | 2010-06-16 | 明治乳业株式会社 | Composition against infection with rotavirus and process for producing the same |
US20060269560A1 (en) * | 2005-05-24 | 2006-11-30 | Savarino Stephen J | Anti-adhesin based passive immunoprophlactic |
EP2445925A1 (en) * | 2009-06-25 | 2012-05-02 | Bristol-Myers Squibb Company | Protein purification by caprylic acid (octanoic acid) precipitation |
DK2750701T3 (en) | 2011-09-12 | 2016-01-11 | Scandinavian Biopharma Holding Ab | PROCEDURE FOR INCREASING ETEC-CS6 ANTIGEN PRESENTATION ON CELL SURFACE AND THEREFORE AVAILABLE PRODUCTS |
WO2016073401A1 (en) | 2014-11-03 | 2016-05-12 | Bristol-Myers Squibb Company | Use of caprylic acid precipitation for protein purification |
FR3076294B1 (en) | 2017-12-29 | 2022-01-28 | Lab Francais Du Fractionnement | METHOD FOR PURIFYING ANTIBODIES FROM RAW MILK |
WO2020053661A1 (en) * | 2018-09-13 | 2020-03-19 | Laboratoire Francais Du Fractionnement Et Des Biotechnologies | Methods of purifying antibodies from the milk of transgenic non-human mammals comprising the use of chitosan |
CN111718410B (en) * | 2020-06-05 | 2022-10-11 | 江南大学 | Method for preparing yolk immunoglobulin |
CN116615434A (en) * | 2020-12-04 | 2023-08-18 | 3M创新有限公司 | Filtration unit and method for purification of biological material |
CN114014926B (en) * | 2021-11-20 | 2023-08-18 | 江苏天美健大自然生物工程有限公司 | Method for simply and rapidly preparing high-purity immunoglobulin G1 and G2 from bovine coloctrum |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5017372A (en) * | 1986-04-14 | 1991-05-21 | Medicis Corporation | Method of producing antibody-fortified dry whey |
FR2657612A1 (en) * | 1990-02-01 | 1991-08-02 | Armines | PROCESS FOR THE SELECTIVE EXTRACTION AND / OR PREPURIFICATION OF PROTEINS CONTAINED IN LACT PRODUCTS. |
-
1996
- 1996-10-04 CA CA002233935A patent/CA2233935A1/en not_active Abandoned
- 1996-10-04 JP JP9514465A patent/JPH11512746A/en active Pending
- 1996-10-04 EP EP96934050A patent/EP0859783A1/en not_active Withdrawn
- 1996-10-04 WO PCT/US1996/015945 patent/WO1997012901A1/en not_active Application Discontinuation
- 1996-10-04 AU AU72565/96A patent/AU7256596A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JPH11512746A (en) | 1999-11-02 |
EP0859783A1 (en) | 1998-08-26 |
CA2233935A1 (en) | 1997-04-10 |
WO1997012901A1 (en) | 1997-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4188396A (en) | Processed whey protein and process for manufacturing the same | |
AU5332196A (en) | Method for protein folding | |
AU4767396A (en) | Process for preparing 2-oxindoles and n-hydroxy-2-oxindoles | |
AU4698396A (en) | Process for modifying surfaces | |
AU5856196A (en) | Method for preparing blend products | |
EP0747789A3 (en) | Automated system for production facility | |
AU3840397A (en) | Milk substitute and process for its manufacture | |
AU7298696A (en) | Hydroformylation process | |
AU4776096A (en) | Whey treatment process | |
AU4188296A (en) | Processed whey protein | |
AU4838996A (en) | Process for tetraazacycloalkane preparation | |
AU1683795A (en) | Method for determining protein tertiary structure | |
AU691390B2 (en) | Process for producing N-arylhydroxylamines and N-hetarylhydroxylamines | |
AU6971796A (en) | Process for manufacturing fat-enriched foods | |
AU7696896A (en) | Dairy product and process for making same | |
AU7256596A (en) | Process for isolating immunoglobulins in whey | |
AU5257896A (en) | Process for preparing olanzapine | |
AU1419395A (en) | Process for fractionating whey proteins and the components so obtained | |
AU7930494A (en) | Intermediate and process for making | |
AU7156596A (en) | Process for preparing hemipotassium phosphate | |
AU7567896A (en) | Method for washing bottles | |
AU1532599A (en) | Method for publishing quick-reference bibles | |
AU7218196A (en) | Method for producing computer-controlled services | |
AU7562996A (en) | Process for preparing dioxoazabicyclohexanes | |
AU1118797A (en) | Process |